Waxman/Hatch Reform Should Await Pending Supreme Court Decision – Hatch
Executive Summary
Congress should wait for an upcoming Supreme Court ruling on the "doctrine of equivalents" before beginning serious work on re-drafting the Waxman/Hatch Act, Sen. Orrin Hatch (R-Utah) said
You may also be interested in...
Patent Infringement Claims Clarified In Festo Ruling
A federal appeals court decision in the Festo case further clarifies the circumstances under which pharmaceutical patent holders can assert infringement claims under the doctrine of equivalents
Patent Infringement Claims Clarified In Festo Ruling
A federal appeals court decision in the Festo case further clarifies the circumstances under which pharmaceutical patent holders can assert infringement claims under the doctrine of equivalents
Ribavirin ANDAs Await ICN Petition; FDA Generic Rule Takes Effect
The delay in approval for generic versions of Schering-Plough's Rebetol (ribavirin) illustrates one limitation of FDA's revised Waxman/Hatch regulations